Key takeaways
- Illustrate the CRM overlap between T2D, HF and CKD, and why having one of these conditions increases the risk of developing others
- Understand the burden of cardio-renal-metabolic disease on the UK health system and at a neighbourhood level
- Outline the current NHS policy related to CRM care and explore how clinical pharmacists can apply them in practice
- Explore how to identify and risk stratify different patient populations with risk factors for CRM disease, using eGFR and uACR to detect and code patients early for CKD
- Discuss patient case studies, resources and examples of how to demonstrate value to your practices in the management of patients with CRM conditions
Speakers:
Danny Bartlett, Lead Pharmacist and Senior Lecturer
Mandip Bassi, Senior Clinical Pharmacist and PCN Clinical Pharmacist Manager
Chair: Graham Stretch, Chief Pharmacist and PCPS President
This promotional webinar has been funded and developed by Boehringer Ingelheim and is for UK healthcare professionals only